Zeillinger R, Eder S, Schneeberger C, Ullrich R, Speiser P, Swoboda H
Department of Obstetrics and Gynecology, University of Vienna, Austria.
Anticancer Res. 1996 Jan-Feb;16(1):449-53.
In order to determine possible overexpression of cathepsin D and PAI-1 (plasminogen activator inhibitor) in head and neck tumours, cytosols from 92 primary squamous cell carcinomas (SCC), 19 lymph node metastases and 24 adjacent normal tissue samples were examined. For both cathepsin D and PAI-1, significantly elevated concentrations in SCC compared to normal tissue were found, even in pairwise comparison. Moreover, significantly higher cathepsin D and PAI-1 concentration in lymph node metastases than in corresponding normal tissue were also present. The conclusion was drawn that cathepsin D and PAI-1 may play a specific role in the biology of head and neck SCC.
为了确定组织蛋白酶D和PAI-1(纤溶酶原激活物抑制剂)在头颈部肿瘤中是否可能过度表达,研究人员检测了92例原发性鳞状细胞癌(SCC)、19例淋巴结转移灶以及24例相邻正常组织样本的胞质溶胶。对于组织蛋白酶D和PAI-1,与正常组织相比,即使在两两比较中,SCC中的浓度也显著升高。此外,淋巴结转移灶中的组织蛋白酶D和PAI-1浓度也明显高于相应的正常组织。由此得出结论,组织蛋白酶D和PAI-1可能在头颈部SCC的生物学过程中发挥特定作用。